The Discounted Cash Flow (DCF) valuation of Regeneron Pharmaceuticals Inc (REGN) is 800.33 USD. With the latest stock price at 1,078.63 USD, the upside of Regeneron Pharmaceuticals Inc based on DCF is -25.8%.
Range | Selected | |
WACC / Discount Rate | 6.9% - 9.4% | 8.2% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 541.16 - 1,652.72 | 800.33 |
Upside | -49.8% - 53.2% | -25.8% |